Inhibiting enzymes in the cell may lead to development and proliferation of cancer cells

Mount Sinai researchers identify new targets that cause abnormal cell division

2013-04-25

(Press-News.org) Blocking certain enzymes in the cell may prevent cancer cell division and growth, according to new findings from researchers at the Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai. The discovery is published in the April 25, 2013 issue of the journal Molecular Cell.

In order to divide, a cell needs to create copies of its genetic material to provide to the new cells, called the "daughter" cells. Several enzymes in the cells, called cyclin dependent kinases (CDKs), act as the traffic cops for this process, making sure that DNA is copied correctly and determining when the cell should move into the next stage of division. Each CDK has a different responsibility during cell division. For example, CDK1 promotes the segregation of DNA into the new daughter cells; CDK4 and 6 act on a tumor suppressor gene; and CDK7 plays an important role in DNA transcription into RNA.

When the cell reaches a stage called the "restriction point," it has passed the threshold where division can be safely stopped—the point of no return. For years, scientists have been working to inhibit the activity of these CDK enzymes in cancer cells before they reach the restriction point, so that that cell division stops and cancer cannot proliferate.

Led by Robert Fisher, MD, PhD, Associate Professor of Structural and Chemical Biology at Mount Sinai, the research team evaluated human colon cancer cells in a petri dish to assess the activity of CDKs. Previous research had shown that CDK7 was a critical enzyme in cell division, but the team wanted to learn how its activity influenced other CDKs; specifically, CDK4 and CDK6, two critical enzymes that act prior to the restriction point and whose regulation is not completely understood.

"While we know that CDK7 plays an essential role in all cells, its precise activity and specific targets in the cell remained unclear," said Dr. Fisher. "CDK4 and CDK6 have also been elusive targets in our research, and we wanted to learn how CDK7 affected them."

Turning off CDK4 and CDK6 has been shown to be effective in blocking division of some cancer cells and is currently being tested in clinical trials. The new study suggests that turning off CDK7 might be equally or more effective, making all three enzymes viable therapeutic targets for the prevention of cancer cell proliferation. Taking advantage of a unique method they developed to control CDK activity in human cells, the research team found that when they "turned off" the activity of CDK7, CDK4 and CDK6 were also inactivated rapidly. This makes sense, because CDK7 is able to activate both CDK4 and CDK6 in the test tube, enabling them to modify a key tumor suppressor protein, which is thought to be how they promote cancer cell growth and division.

"These findings complete the story of CDK activation in human cells, in which one CDK is capable of activating others," said Dr. Fisher. "Now, we want to evaluate what signaling pathway earlier in the cell division process leads to CDK7 activation, so that it can in turn activate CDK4 and CDK6. This pathway may be an important therapeutic target for cancer, and possibly other diseases as well."

Next, Dr. Fisher and his team plan to find out what is happening upstream, or earlier, in the cell division process that turns up the activity of CDK7, and also to learn more specifically how it is interacting with CDK4 and CDK6.

### The study was supported by a grant to Dr. Fisher from the National Institutes of Health, and by a pre-doctoral training grant from the NIH to the lead author, Miriam Merzel Schachter, a PhD candidate in Dr. Fisher's laboratory.

About The Mount Sinai Medical Center The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School of Medicine at Mount Sinai is one of the leading medical schools in the United States. The Icahn School of Medicine is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty members in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Mount Sinai is one of just 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and by U.S. News & World Report and whose hospital is on the U.S. News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.

For more information, visit http://www.mountsinai.org/. Find Mount Sinai on: Facebook: http://www.facebook.com/mountsinainyc
Twitter @mountsinainyc
YouTube: http://www.youtube.com/mountsinainy

ELSE PRESS RELEASES FROM THIS DATE:

Probiotics found to reduce hepatic encephalopathy

2013-04-25

Amsterdam, The Netherlands,Thursday 25 April 2013: Probiotics could emerge as a treatment plan to manage hepatic encephalopathy (HE) therapy after a new study announced at the International Liver Congress™ 2013 found they significantly reduced development of the notoriously difficult-to-treat disease. The study analysed the efficacy of probiotics in preventing the development of HE in 160 cirrhotic patients over a period of approximately nine months and found significant improvements in reducing patients' arterial ammonia levels after three months of treatment with probiotics. ...

High performance semiconductor spray paint could be a game changer for organic electronics

2013-04-25

Researchers at Wake Forest University's Organic Electronics group have come up with a novel solution to one of the biggest technological barriers facing the organic semiconductor industry today. Oana Jurchescu, an assistant professor of physics, and a team of researchers developed a high performance organic semiconductor 'spray paint' that can be applied to large surface areas without losing electric conductivity. This is a potentially game changing technology for a number of reasons. Organic thin film transistors are currently deposited by one of three methods. Drop ...

Pushing the boundaries of transcription

2013-04-25

Like musicians in an orchestra who have the same musical score but start and finish playing at different intervals, cells with the same genes start and finish transcribing them at different points in the genome. For the first time, researchers at EMBL have described the striking diversity of messenger RNAs (mRNAs) that such start and end variation produces, even from the simple genome of yeast cells. Their findings, published today in Nature, shed new light on the importance of mRNA boundaries in determining the functional potential of genes. Hundreds of thousands of ...

The peculiar life history of Middle American Stenamma ants

2013-04-25

Stenamma is a cryptic "leaf-litter" ant genus that occurs in moderately humid to wet forest habitats throughout the Holarctic region, Central America, and part of northwestern South America (Colombia and Ecuador). The genus was thought to be restricted primarily to the temperate zone, but recent collecting efforts have uncovered a large variety of Neotropical forms, which rival the Holarctic species in terms of morphological and behavioral diversity. The Middle American clade of Stenamma is revised in a paper published in the open access journal ZooKeys to recognize 40 ...

Discovery of a gene that controls 3 different diseases

2013-04-25

An international research consortium led by the Universitat Autònoma de Barcelona (UAB), the CIBERER and the University of Wurzburg (Germany) has discovered a gene that can cause three totally different diseases, depending on how it is altered. The researchers, using next-generation massive ultrasequencing techniques, have sequenced the over 20,000 genes of a Fanconi anaemia patient's genome. By adopting this strategy they have succeeded in identifying pathogenic mutations responsible for this disease in the ERCC4 gene, which had already been linked to two other rare ...

Metabolic disorders predict the hardening of the arterial walls already in childhood

2013-04-25

Metabolic disorders, such as excess abdominal fat, raised blood pressure, higher levels of insulin, glucose and triglycerides and lower levels of the beneficial HDL cholesterol can be found in children as young as 6 to 8 years of age, according to a study carried out at the University of Eastern Finland. These metabolic risk factors often accumulate in overweight children and, in the newly published study, this accumulation was linked with mild artery wall stiffness. Of single disorders, higher levels of insulin, triglyceride and blood pressure were associated with artery ...

Study reveals dramatic changes in global attitudes toward domestic violence

2013-04-25

WASHINGTON, DC, April 25, 2013 — Global attitudes about domestic violence changed dramatically during the first decade of the 2000s, according to a new University of Michigan study that analyzes data from 26 low- and middle-income countries. Nigeria had the largest change, with 65 percent of men and 52 percent of women rejecting domestic violence in 2008, compared with 48 percent and 33 percent, respectively, in 2003. In the study, which appears in the April issue of the American Sociological Review, University of Michigan researcher Rachael Pierotti analyzes data ...

Study by Worcester Polytechnic Institute professor produces first edition of a bookworm's genome

2013-04-25

WORCESTER, Mass. -- It has co-existed quietly with humans for centuries, slurping up the spillage in beer halls and gorging on the sour paste used to bind books. Now the tiny nematode Panagrellus redivivus (P.redivivus) has emerged from relative obscurity with the publication of its complete genetic code. Further study of this worm, which is often called the beer-mat worm or, simply, the microworm, is expected to shed new light on many aspects of animal biology, including the differences between male and female organisms and the unique adaptations of parasitic worms. Using ...

With wave of the hand, Carnegie Mellon researchers create touch-based interfaces

2013-04-25

PITTSBURGH—Researchers previously have shown that a depth camera system, such as Kinect, can be combined with a projector to turn almost any surface into a touchscreen. But now researchers at Carnegie Mellon University have demonstrated how these touch-based interfaces can be created almost at will, with the wave of a hand. CMU's WorldKit system enables someone to rub the arm of a sofa to "paint" a remote control for her TV or swipe a hand across an office door to post his calendar from which subsequent users can "pull down" an extended version. These ad hoc interfaces ...

Leading leukemia experts: High leukemia treatment costs may be harming patients

2013-04-25

(WASHINGTON, April 25, 2013) – The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today in Blood, the Journal of the American Society of Hematology (ASH). Blood Forum articles are a new feature in the journal that present well documented opinions on controversial topics and ...

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

[Press-News.org] Inhibiting enzymes in the cell may lead to development and proliferation of cancer cells
Mount Sinai researchers identify new targets that cause abnormal cell division

Inhibiting enzymes in the cell may lead to development and proliferation of cancer cells

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: